Siemens completes acquisition of GSD

SIEMENSFollowing the announcement in January 2007 of its intent, Siemens Medical Solutions announced today that it has received antitrust approval and completed its acquisition of Gesellschaft fur Systemforschung und Dienstleistungen im Gesundheitswesen mbH (GSD), headquartered in Berlin. The new entity, Siemens Medical Solutions GSD GmbH, will remain a separate legal entity, operating as a wholly owned subsidiary of Siemens Medical Solutions as part of the Health Services (HS) Division. With this acquisition Siemens strengthens its position in the European healthcare IT market.

With more than 300 customers in 14 countries, GSD is a leading health information systems (HIS) company. With the addition of GSD's i.s.h.med and i.c.m.health product lines, the move enhances Siemens' global healthcare IT portfolio and infuses additional industry expertise into its product and service offerings for the European market. GSD generated a revenue of 23.6 million EUR and employed 167 people in fiscal year 2006 (ended December 31).

"We are pleased to officially welcome the talent and resources of GSD into our trendsetting healthcare IT portfolio," said Erich R. Reinhardt, member of the Managing Board of Siemens AG, and President and CEO of Siemens Medical Solutions. "As with our continued investments in our Soarian healthcare process management solution, which is distinguished by its unique architecture and workflow engine, and with the internationally successful health information system, i.s.h.med, we see tremendous potential for best practice sharing and optimized service and support for our customers through this investment in GSD."

The combined product portfolio is unique in its regional and functional market coverage, enabling Siemens to tailor its solution offerings for customers at various levels of IT sophistication and maturity.

"We remain steadfast in our commitment to improving the quality and reducing the cost of healthcare through IT, which has become an essential component of our global strategy as we move toward more personalized medicine," Reinhardt added. "Today, we are taking an important step in improving our market position in Germany and expanding our presence in Europe. Additionally, we have high expectations that the combined business expertise and industry knowledge of the HS and GSD teams will ensure that our product and service innovation continues, our customers are well-positioned to achieve their desired outcomes, and that we are successful in all markets we serve."

After the formation of Siemens Medical Solutions Diagnostics, following the acquisitions of Diagnostic Products Corporation (DPC) and Bayer Diagnostics, the acquisition of GSD is Siemens Medical Solutions' third acquisition in the past three quarters. These moves support Siemens' strategy of building the industry's first full service diagnostics company that combines diagnostic imaging, laboratory diagnostics and clinical information technology under one roof along the value chain.

Gesellschaft fur Systemforschung und Dienstleistungen im Gesundheitswesen mbH (GSD) is one of Europe's leading manufacturers and service providers of IT solutions for hospitals. Its circle of users comprises over 268 hospitals and hospital operators around the world and GSD provided support for over 54 hospitals in different SAP projects. For the past 25 years GSD's has been providing the healthcare sector with all the IT solutions required to run a modern hospital: from software development to hardware solutions, over planning, support and implementation of networks, to the complete outsourcing of system operations. The company generated a revenue of 23.6 million Euro and employed 167 people in the fiscal year 2006 (ended December 31). Further information at www.gsd.de

Siemens AG (Berlin and Munich) is a global powerhouse in electrical engineering and electronics. The company has around 475,000 employees (incl. discontinued operations) working to develop and manufacture products, design and install complex systems and projects, and tailor a wide range of services for individual requirements. Siemens provides innovative technologies and comprehensive know-how to benefit customers in over 190 countries. Founded more than 155 years ago, the company focuses on the areas of Information and Communications, Automation and Control, Power, Transportation, Medical, and Lighting. In fiscal 2006 (ended September 30), Siemens had sales from continuing operations of EUR 87.3 billion and net income of EUR 3.033 billion, according to U.S. GAAP. Further information is available on the Internet at: www.siemens.com

Siemens Medical Solutions of Siemens AG (NYSE:SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics - such as Diagnostic Products Corporation and Bayer Diagnostics - mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30). Further information can be found by visiting www.siemens.com/medical

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...